Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
Go back to Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product| Philip Morris International, Inc. (NYSE: PM) | Delayed: 178.40 -1.04 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $179.44 | 52 Week High | $104.20 | |||
| Open | $179.58 | 52 Week Low | $83.33 | |||
| Day High | $180.47 | P/E | 33.72 | |||
| Day Low | $177.04 | EPS | $5.29 | |||
| Volume | 11,732,385 | |||||
| PMI Group, Inc. (NYSE: PMI) | Delayed: 0.18 -0.01 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $4.14 | |||
| Open | $0.18 | 52 Week Low | $0.15 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $-5.35 | |||
| Volume | 4,493,782 | |||||
